Acceleron Pharma

Entity > Corporation > US > New York City New York > Acceleron Pharma

About Acceleron Pharma

Industry: Business & Industrial > Pharmaceuticals & Biotech

More information about Acceleron Pharma

Company Attribute Value
Name Acceleron Pharma
Url acceleronpharma
Google google
Wikidata wikidata

Acceleron Pharma

us

New York City, US
11 Jul 2024

New York City, US
11 Jul 2024

Acceleron Pharma

All
News
Images
Maps
Videos
More
Page: 1 Desktop | Laptop Devices

https://www.merck.com › news › merck-to-acquire-acc...
Merck to Acquire Acceleron Pharma Inc.
Sep 30, 2021 — Under the terms of the acquisition agreement, Merck, through a subsidiary, will initiate a tender offer to acquire all outstanding shares of ...
https://en.wikipedia.org › wiki › Acceleron_Pharma
Acceleron Pharma
Acceleron Pharma, Inc. is an American clinical stage biopharmaceutical company based in Cambridge, Massachusetts with a broad focus on developing medicines ...
https://clinicaltrials.acceleronpharma.com/
Welcome to Acceleron Clinical Trials
Information about what is provided on the website for Patients and Healthcare Professional and Acceleron´s clinical trial transparency commitment.
https://www.linkedin.com/company/acceleron-pharma
Acceleron Pharma
Acceleron Pharma | 18601 followers on LinkedIn. Accelerating drug discovery to transform patients' lives | Effective 11/22/21, Acceleron ...
https://www.merck.com › news › merck-completes-acq...
Merck Completes Acquisition of Acceleron Pharma Inc.
Nov 22, 2021 — “Fueled by Acceleron's groundbreaking research, we are excited to explore the opportunities and possibilities ahead to reach even more patients ...
https://www.forbes.com › companies › acceleron-pharma
Acceleron Pharma | XLRN Stock Price, Company Overview ...
Acceleron Pharma, Inc. is a biopharmaceutical company, which engages in the discovery, development, and commercialization of therapeutics to treat serious.
https://www.bloomberg.com › news › articles › accelero...
Acceleron Is in Advanced Talks for $11 Billion Sale
Sep 24, 2021 — Drugmaker Acceleron Pharma Inc. is in advanced discussions to be acquired by a large pharmaceutical company for about $180 a share in cash, ...
https://clinicaltrials.acceleronpharma.com › who-we-are
Learn About Acceleron
Acceleron is dedicated to the discovery and development of innovative, life-changing medicines for patients with a wide range of serious and rare diseases. Our ...
https://www.pharmaceutical-technology.com › news
Merck agrees to acquire Acceleron Pharma for $11.5bn
Oct 1, 2021 — Merck has signed a definitive agreement to acquire all outstanding shares of Acceleron Pharma for a total equity value of $11.5bn in cash.
https://www.barrons.com › articles › merck-stock-price-...
Merck Closes Biggest Biotech Deal of the Year
Nov 22, 2021 — Merck said it completed its $11.5 billion acquisition of Acceleron Pharma, disappointing some investors in the biotech who had hoped for a ...
Related Searches
Related Searches
Acceleron Pharma stock
Acceleron Pharma careers
Acceleron pharma merck
Knowledge Panel
Knowledge Panel

Acceleron Pharma (Biotech company)

Acceleron Pharma, Inc. is an American clinical stage biopharmaceutical company based in Cambridge, Massachusetts with a broad focus on developing medicines that regulate the transforming growth factor ...

en.wikipedia.org/wiki/Acceleron_Pharma
  • CEO : Habib Dable (Dec 1, 2016–)
  • Parent organizations : Merck Sharp & Dohme, Merck Sharp & Dohme LLC
  • Headquarters : Boston, MA
  • Founded : 2003
  • Location : Cambridge, Massachusetts
  • Number of employees : 225 (Dec 2019)

All information on this page is taken from publicly available sources, and the analysis we provide is a representation of Google's search results for the entity and does not represent any opinion or judgement about the entity by Kalicube itself. If you disagree with this analysis, please contact us and cite this reference : 86923